cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Icon Public Limited Company
3 own
3 watching
Current Price
$244.02
$-1.31
(-0.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
19,923.08M
52-Week High
52-Week High
279.8
52-Week Low
52-Week Low
171.43
Average Volume
Average Volume
0.64M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
42.6421
iconMarket Capitalization19,923.08M
icon52-Week High279.8
icon52-Week Low171.43
iconAverage Volume0.64M
iconDividend Yield--
iconP/E Ratio42.6421
What does the Icon Public Limited Company do?
ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. Its clinical development services comprise product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk-based monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services. The company's clinical development services also comprise interactive response technologies, electronic endpoint adjudication, medical imaging, adaptive trial design and execution, medical device and biosimilar trial, functional, strategic resourcing, sample analyses, safety testing, microbiology, custom flow cytometry, biomarker development, bioanalysis, immunoassay development, patient registries, outcomes research, health economics, market access and commercialization, drug price consulting, and healthcare and scientific communication services, as well as research trials for US government agencies, electronic transmission of test results, and electronic patient reported outcomes. ICON Public Limited Company was founded in 1990 and is headquartered in Dublin, Ireland.
Read More
News & Events about Icon Public Limited Company.
Business Wire
26days ago
ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2023. For the full year 2023, revenue is expected to be in the range of $7,940 - $8,340 million, representing growth...
TheStreet.com
2 months ago
The cruise line likes to try new things, but its latest idea might be pushing boundaries too far.The cruise line likes to try new things, but its latest idea might be pushing boundaries too far.Cruise ships offer a mix of family fun and adult access. If you cruise on Royal Caribbean (RCL) - Get Free...
BizJournals.com - Nat'l Business News
2 months ago
Icon Technology Inc. and Lennar Home Corp. on Nov. 10 revealed that the startup's first foray into the volume homebuilding game will be the Genesis Collection at the Wolf Ranch master-planned community west of I-35 along U.S. Highway 29 in Georgetown, about 30 miles north of Austin. Construction is ...
TheStreet.com
3 months ago
Icon of the Seas will have a startling number of things that are new to the cruise line (and maybe to cruising).Icon of the Seas will have a startling number of things that are new to the cruise line (and maybe to cruising).When Oasis of the Seas first went into service in 2008, it changed the ...
Fool.com Headlines
3 months ago
They're not going to need a bigger boat. On Thursday, cruise giant Royal Caribbean unveiled plans for a new vessel, the Icon of the Seas, which...For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn ...
Frequently Asked Questions
Frequently Asked Questions
What is Icon Public Limited Company share price today?
plus_minus_icon
Can Indians buy Icon Public Limited Company shares?
plus_minus_icon
How can I buy Icon Public Limited Company shares from India?
plus_minus_icon
Can Fractional shares of Icon Public Limited Company be purchased?
plus_minus_icon
What are the documents required to start investing in Icon Public Limited Company stocks?
plus_minus_icon
What is today’s traded volume of Icon Public Limited Company?
plus_minus_icon
What is today’s market capitalisation of Icon Public Limited Company?
plus_minus_icon
What is the 52-Week High and Low Range of Icon Public Limited Company?
plus_minus_icon
What percentage is Icon Public Limited Company down from its 52-Week High?
plus_minus_icon
What percentage is Icon Public Limited Company up from its 52-Week Low?
plus_minus_icon
Current Price
$244.02
$-1.31
(-0.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
$470.88
$-9.61 (-2.00 %)
Steris Corp.
Steris Corp.
$219.03
$-1.83 (-0.83 %)
Charles River Laboratories International
Charles River Laboratories International
$250.35
$-9.57 (-3.68 %)
Bio-Techne Corp.
Bio-Techne Corp.
$79.16
$-1.69 (-2.09 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
$470.88
$-9.61 (-2.00 %)
Steris Corp.
Steris Corp.
$219.03
$-1.83 (-0.83 %)
Charles River Laboratories International
Charles River Laboratories International
$250.35
$-9.57 (-3.68 %)
Bio-Techne Corp.
Bio-Techne Corp.
$79.16
$-1.69 (-2.09 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00